Abstract 5530: Metastasis founder cells activate immunsuppression early in human metastatic colonization

Severin Guetter(University Hospital Regensburg), Melanie Werner‐Klein(University Hospital Regensburg), Mark Berneburg(University Hospital Regensburg), Huiqin Koerkel-Qu(University of Regensburg), Philipp Renner(Robert Bosch Hospital), Sebastian Haferkamp(University Hospital Regensburg), Christian Werno(Fraunhofer Institute for Toxicology and Experimental Medicine), Lisa Schmidleithner(University Hospital Regensburg), Courtney Koenig(University of Regensburg), Kathrin Schambeck(University Hospital Regensburg), Kathrin Weidele(Fraunhofer Institute for Toxicology and Experimental Medicine), Sebastian Scheitler(University of Regensburg), Armin Braun(Medizinische Hochschule Hannover), Katharina Limm(University of Regensburg), Veronika Naimer(University of Regensburg), Florian Weber(University of Augsburg), Christoph A. Klein(University Hospital Regensburg), Beatrix Cucuruz(University Hospital Regensburg), Reinhard Rachel(University of Regensburg), Felix Baumann(University of Regensburg), Steffi Treitschke(Fraunhofer Institute for Toxicology and Experimental Medicine), Anja Ulmer(University of Tübingen), Leonhard Guttenberger(University of Regensburg), Hanna Jaser(University of Regensburg), Tonia Bargmann(Fraunhofer Institute for Toxicology and Experimental Medicine), Marie Katzer(University Hospital Regensburg), Aleksandra Markiewicz(University of Regensburg)
Cancer Research
March 22, 2024
Cited by 0


Related Papers